We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTA icon
1326
Enanta Pharmaceuticals
ENTA
$362M
-69
Closed -$1K
EPR.PRC icon
1327
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$154M
-6,180
Closed -$115K
FATE icon
1328
Fate Therapeutics
FATE
$276M
-360
Closed -$1K
KYNB
1329
Kyntra Bio
KYNB
$27.7M
-15
Closed
FHTX icon
1330
Foghorn Therapeutics
FHTX
$278M
-168
Closed -$1K
GBIO
1331
DELISTED
Generation Bio
GBIO
-19
Closed -$1K
GLUE icon
1332
Monte Rosa Therapeutics
GLUE
$1.82B
-136
Closed -$1K
B
1333
Barrick Mining
B
$60.9B
-6,052
Closed -$88K
GOSS icon
1334
Gossamer Bio
GOSS
$101M
-260
Closed
HLVX
1335
DELISTED
HilleVax
HLVX
-134
Closed -$2K
HYLN icon
1336
Hyliion Holdings
HYLN
$576M
-34,055
Closed -$40K
IGMS
1337
DELISTED
IGM Biosciences
IGMS
-88
Closed -$1K
NBP
1338
NovaBridge Biosciences American Depositary Shares
NBP
$186M
-144
Closed
IMRX icon
1339
Immuneering
IMRX
$262M
-76
Closed -$1K
INO icon
1340
Inovio Pharmaceuticals
INO
$84.7M
-60
Closed
IPSC icon
1341
Century Therapeutics
IPSC
$364M
-159
Closed
KOD icon
1342
Kodiak Sciences
KOD
$2.51B
-151
Closed
KPTI icon
1343
Karyopharm Therapeutics
KPTI
$155M
-9
Closed
KRNT icon
1344
Kornit Digital
KRNT
$679M
-9,496
Closed -$180K
KZR
1345
DELISTED
Kezar Life Sciences
KZR
-28
Closed
LLYVK icon
1346
Liberty Live Group Series C
LLYVK
$9.54B
-518
Closed -$17K
MASS icon
1347
908 Devices
MASS
$311M
-4,419
Closed -$29K
MCRB icon
1348
Seres Therapeutics
MCRB
$45.3M
-25
Closed -$1K
MLAB icon
1349
Mesa Laboratories
MLAB
$551M
-4,603
Closed -$484K
MRSN
1350
DELISTED
Mersana Therapeutics
MRSN
-16
Closed -$1K

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.